Tracer library / [188Re]Re-perrhenate

Structure of perrhenate (unlabelled parent compound, from PubChem) — Unlabelled parent compoundPubChem CID 139584

[188Re]Re-perrhenate

Also written as [Re-188]perrhenate

Radionuclide: Re-188 t½ 1020 min
Modality: Therapy
Production route: —
Stage: —
Syntheses indexed: 2

Radiolabelling starting material

What it is

Compound class: sodium/potassium perrhenate ([188Re]ReO4-), radiolabelling starting material for 188Re radiopharmaceuticals
Target / mechanism: —
Clinical application: Used as a negative control compound in radiotherapy studies of receptor-positive human prostate adenocarcinoma with somatostatin analogue PMID 8567120
Theranostic pair: —

Published syntheses

Module	Cassette	Purification	Yield %	RCP %	Precursor / supplier	Source
Manual synthesis n/a	—	—	—	—	18B7 IgG1	17875799 2007 Clin Cancer Res radiolabeled with 188Re
Manual synthesis n/a	—	—	—	—	—	11272362 1999 Cardiovasc Radiat Med Rhenium-188 was obtained as [188Re]-sodium perrhenate by saline elution of an alumina-based 188W/188Re generator system

Need this precursor?We can point you to suppliers for [188Re]Re-perrhenate, or handle the enquiry for you.

Get in touch

Notes

Added at stage 21 from therapy-discovered.xlsx (bulk PubMed search by isotope/therapy-type/known-agent, not individually researched yet) -- 2 articles found. Target/mechanism, clinical application, indications, approval and precursor fields still need per-agent research and are intentionally left empty.